Company Description
BeiGene is a global biotechnology company, expediting development of a diverse pipeline of novel therapeutics to improve treatment outcomes and access for patients worldwide. Our growing global team spans five continents, with administrative offices in Beijing, China; Cambridge, U.S.; and Basel, Switzerland. Our internally discovered medicine BRUKINSA® (zanubrutinib) is approved in more than 60 markets, including the United States, China, the European Union, Canada, Australia, South Korea.
Categories (5)
Lymphoma Treatment, Myeloproliferative Neoplasms Treatment
New Product
2955 Campus Drive, 2nd Floor
San Mateo, CA 94403
United States